Table 1 Demographic variables of patients with functional movement disorders and controls.
From: Cerebrospinal fluid glutamate changes in functional movement disorders
Patients with FMD (N = 8) | Controls (N = 9) | Significance | |
|---|---|---|---|
Gender, female, n (%) | 8 (100) | 7 (77.8) | X2 = 2.015, p = 0.471 |
Age (years), mean (SD) | 47.13 (16.93) | 42.00 (17.41) | t = −0 to 614, p = 0.549 |
PMDRS score, mean (SD) | 6.2 (3.8) | ||
Time elapsed between date of the lumbar puncture and date of CSF amino acids measurements (months), mean (SD) | 10.50 (10.57) | 11.78 (4.02) | t = 0.337, p = 0.741 |
Time elapsed between onset of symptoms and date of lumbar puncture (months), mean (SD) | 5.6 (3.2) | 4.6 (2.6) | t = 0.244, p = 0.543 |
